HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Regulatory affairs staff

Executive Summary

Former Center for Drug Evaluation & Research Office of Compliance Director David Horowitz officially joins ORA in the new position of deputy for compliance policy. His responsibilities include developing and implementing "risk-based approaches to optimize, and maximize the impact of, ORA's programs and activities," agency says. Diana Kolaitis also assumes the new position of ORA deputy for field operations. Both Horowitz and Kolaitis have been fulfilling their responsibilities in an acting capacity since July 2005, with their permanent appointments effective Jan. 8...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS046764

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel